Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Science
    August 2021
  1. QU K, Ke Z, Zila V, Anders-Osswein M, et al
    Maturation of the matrix and viral membrane of HIV-1.
    Science. 2021;373:700-704.
    >> Share

  2. HIKICHI Y, Freed EO
    Maturation of HIV-1.
    Science. 2021;373:621-622.
    >> Share

    July 2021
  3. LOPMAN BA, McQuade ETR
    Using viral load to model disease dynamics.
    Science. 2021;373:280-281.
    >> Share

    June 2021
  4. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    >> Share

    February 2021
  5. WANG Q, Gao H, Clark KM, Mugisha CS, et al
    CARD8 is an inflammasome sensor for HIV-1 protease activity.
    Science. 2021 Feb 4. pii: science.abe1707. doi: 10.1126/science.abe1707.
    >> Share

    January 2021
  6. RAPPAZZO CG, Tse LV, Kaku CI, Wrapp D, et al
    Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Science. 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.
    >> Share

  7. HIE B, Zhong ED, Berger B, Bryson B, et al
    Learning the language of viral evolution and escape.
    Science. 2021;371:284-288.
    >> Share

    December 2020
  8. LARSEN MD, de Graaf EL, Sonneveld ME, Plomp HR, et al
    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Science. 2020 Dec 23. pii: science.abc8378. doi: 10.1126/science.abc8378.
    >> Share

  9. KAISER J
    HIV researcher named to lead battered CDC.
    Science. 2020;370:1256.
    >> Share

    November 2020
  10. ROARK RS, Li H, Williams WB, Chug H, et al
    Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.
    Science. 2020 Nov 19. pii: science.abd2638. doi: 10.1126/science.abd2638.
    >> Share

    October 2020
  11. BESTER SM, Wei G, Zhao H, Adu-Ampratwum D, et al
    Structural and mechanistic bases for a potent HIV-1 capsid inhibitor.
    Science. 2020;370:360-364.
    >> Share

  12. CHRISTENSEN DE, Ganser-Pornillos BK, Johnson JS, Pornillos O, et al
    Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro.
    Science. 2020;370.
    >> Share

    September 2020
  13. BASTARD P, Rosen LB, Zhang Q, Michailidis E, et al
    Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4585. doi: 10.1126/science.abd4585.
    >> Share

  14. ZHANG Q, Bastard P, Liu Z, Le Pen J, et al
    Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
    Science. 2020 Sep 24. pii: science.abd4570. doi: 10.1126/science.abd4570.
    >> Share

  15. WOROBEY M, Pekar J, Larsen BB, Nelson MI, et al
    The emergence of SARS-CoV-2 in Europe and North America.
    Science. 2020 Sep 10. pii: science.abc8169. doi: 10.1126/science.abc8169.
    >> Share

    August 2020
  16. COHEN J
    How 'elite controllers' tame HIV without drugs.
    Science. 2020;369:1045.
    >> Share

    July 2020
  17. ABDOOL KARIM Q, Abdool Karim SS
    COVID-19 affects HIV and tuberculosis care.
    Science. 2020;369:366-368.
    >> Share

  18. LV Z, Deng YQ, Ye Q, Cao L, et al
    Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
    Science. 2020 Jul 23. pii: science.abc5881. doi: 10.1126/science.abc5881.
    >> Share

  19. YUAN M, Liu H, Wu NC, Lee CD, et al
    Structural basis of a shared antibody response to SARS-CoV-2.
    Science. 2020 Jul 13. pii: science.abd2321. doi: 10.1126/science.abd2321.
    >> Share

  20. VILLABONA-ARENAS CJ, Hall M, Lythgoe KA, Gaffney SG, et al
    Number of HIV-1 founder variants is determined by the recency of the source partner infection.
    Science. 2020;369:103-108.
    >> Share

    June 2020
  21. ROGERS TF, Zhao F, Huang D, Beutler N, et al
    Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.
    Science. 2020 Jun 15. pii: science.abc7520. doi: 10.1126/science.abc7520.
    >> Share

  22. WEC AZ, Wrapp D, Herbert AS, Maurer DP, et al
    Broad neutralization of SARS-related viruses by human monoclonal antibodies.
    Science. 2020 Jun 15. pii: science.abc7424. doi: 10.1126/science.abc7424.
    >> Share

    May 2020
  23. BEKKER LG, Mizrahi V
    COVID-19 research in Africa.
    Science. 2020;368:919.
    >> Share

  24. VASAVDA C, Ho BK, Snyder SH
    Ease restrictions on U.S. blood donations.
    Science. 2020;368:957.
    >> Share

  25. COHEN J
    Long-acting drug acts like a short-term AIDS vaccine.
    Science. 2020;368:807.
    >> Share

  26. COHEN MS, Corey L
    Combination prevention for COVID-19.
    Science. 2020;368:551.
    >> Share

    April 2020
  27. BROWN JD, Kharytonchyk S, Chaudry I, Iyer AS, et al
    Structural basis for transcriptional start site control of HIV-1 RNA fate.
    Science. 2020;368:413-417.
    >> Share

  28. NORDLING L
    Tested by HIV and TB, South Africa confronts new pandemic.
    Science. 2020;368:117.
    >> Share

    February 2020
  29. COHEN J
    Combo of two HIV vaccines fails its big test.
    Science. 2020;367:611-612.
    >> Share

    January 2020
  30. COOK NJ, Li W, Berta D, Badaoui M, et al
    Structural basis of second-generation HIV integrase inhibitor action and viral resistance.
    Science. 2020 Jan 30. pii: science.aay4919. doi: 10.1126/science.aay4919.
    >> Share

  31. PASSOS DO, Li M, Jozwik IK, Zhao XZ, et al
    Structural basis for strand transfer inhibitor binding to HIV intasomes.
    Science. 2020 Jan 30. pii: science.aay8015. doi: 10.1126/science.aay8015.
    >> Share

    December 2019
  32. HUFFMAN MA, Fryszkowska A, Alvizo O, Borra-Garske M, et al
    Design of an in vitro biocatalytic cascade for the manufacture of islatravir.
    Science. 2019;366:1255-1259.
    >> Share

  33. AGAZIO A, Torres RM
    Ushering along B cells to neutralize HIV.
    Science. 2019;366:1197-1198.
    >> Share

  34. SAUNDERS KO, Wiehe K, Tian M, Acharya P, et al
    Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.
    Science. 2019;366.
    >> Share

    November 2019
  35. COHEN J, Kaiser J
    Gates and NIH join forces on HIV and sickle cell diseases.
    Science. 2019;366:558-559.
    >> Share

    October 2019
  36. STEICHEN JM, Lin YC, Havenar-Daughton C, Pecetta S, et al
    A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
    Science. 2019 Oct 31. pii: science.aax4380. doi: 10.1126/science.aax4380.
    >> Share

    September 2019
  37. ABBINK P, Mercado NB, Nkolola JP, Peterson RL, et al
    Lack of therapeutic efficacy of an antibody to alpha4beta7 in SIVmac251-infected rhesus macaques.
    Science. 2019;365:1029-1033.
    >> Share

  38. BERG J
    Editorial expression of concern.
    Science. 2019;365:991.
    >> Share

  39. IWAMOTO N, Mason RD, Song K, Gorman J, et al
    Blocking alpha4beta7 integrin binding to SIV does not improve virologic control.
    Science. 2019;365:1033-1036.
    >> Share

  40. DI MASCIO M, Lifson JD, Srinivasula S, Kim I, et al
    Evaluation of an antibody to alpha4beta7 in the control of SIVmac239-nef-stop infection.
    Science. 2019;365:1025-1029.
    >> Share

    August 2019
  41. AMAMBUA-NGWA A, Amenga-Etego L, Kamau E, Amato R, et al
    Major subpopulations of Plasmodium falciparum in sub-Saharan Africa.
    Science. 2019;365:813-816.
    >> Share

  42. COHEN J
    Cancer therapy returns to original target: HIV.
    Science. 2019;365:530.
    >> Share


  43. Erratum for the Report: "Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells" by V. Ramsuran, V. Naranbhai, A. Horowitz, Y. Qi, M. P. Martin, Y. Yuki, X. Gao, V. Walker-Sperling, G. Q. Del Prete, D. K. Schneider,
    Science. 2019;365.
    >> Share

    July 2019
  44. COHEN J
    Once-a-year implant shows promise against HIV.
    Science. 2019;365:309.
    >> Share

  45. RAMAN AS, Gehrig JL, Venkatesh S, Chang HW, et al
    A sparse covarying unit that describes healthy and impaired human gut microbiota development.
    Science. 2019;365.
    >> Share

    June 2019
  46. STONE R
    North Korea's HIV epidemic emerges from the shadows.
    Science. 2019;364:1215-1216.
    >> Share

    May 2019
  47. LI G, Jiang Y, Zhang L
    HIV upsurge in China's students.
    Science. 2019;364:711.
    >> Share

  48. GAIHA GD, Rossin EJ, Urbach J, Landeros C, et al
    Structural topology defines protective CD8(+) T cell epitopes in the HIV proteome.
    Science. 2019;364:480-484.
    >> Share

  49. MCMICHAEL AJ, Carrington M
    Topological perspective on HIV escape.
    Science. 2019;364:438-439.
    >> Share

    March 2019
  50. COHEN J
    Tests identify HIV's final redoubt.
    Science. 2019;363:1260-1261.
    >> Share

  51. COHEN J
    Giant prevention study has sobering message.
    Science. 2019;363:1132.
    >> Share

  52. COHEN J
    Has a second person with HIV been cured?
    Science. 2019;363:1021.
    >> Share

    February 2019
  53. SERVICK K
    Unexpected drug emerges for stroke recovery.
    Science. 2019;363:805.
    >> Share

  54. COHEN J
    AIDS push gets mixed reviews.
    Science. 2019;363:680.
    >> Share

    December 2018
  55. SCHONEBERG J, Pavlin MR, Yan S, Righini M, et al
    ATP-dependent force generation and membrane scission by ESCRT-III and Vps4.
    Science. 2018;362:1423-1428.
    >> Share

  56. TOKATLIAN T, Read BJ, Jones CA, Kulp DW, et al
    Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.
    Science. 2018 Dec 20. pii: science.aat9120. doi: 10.1126/science.aat9120.
    >> Share

  57. COHEN J
    U.N. HIV/AIDS agency assailed for culture of harassment.
    Science. 2018;362:1224.
    >> Share

  58. NORMILE D
    For China, a CRISPR first goes too far.
    Science. 2018;362:1091.
    >> Share

  59. COHEN J
    What now for human genome editing?
    Science. 2018;362:1090-1092.
    >> Share

    August 2018
  60. COHEN J
    Monthly shots may replace daily anti-HIV pills.
    Science. 2018;361:740.
    >> Share

    June 2018
  61. COHEN J
    Babies who dodge HIV may not be unscathed.
    Science. 2018;360:1168.
    >> Share

  62. ABDOOL KARIM Q, Abdool Karim SS
    HIV-No time for complacency.
    Science. 2018;360:1153.
    >> Share

  63. COHEN J
    The Sunshine State's dark cloud.
    Science. 2018;360:1176-1179.
    >> Share

  64. COHEN J
    The loyal opposition.
    Science. 2018;360:1175.
    >> Share

  65. COHEN J
    The pill exchange.
    Science. 2018;360:1174.
    >> Share

  66. COHEN J
    Poster couple.
    Science. 2018;360:1172.
    >> Share

  67. COHEN J
    Status symbol.
    Science. 2018;360:1171.
    >> Share

  68. COHEN J
    Dark nights, bright stars.
    Science. 2018;360:1170-1175.
    >> Share

    March 2018
  69. COHEN J
    Concern as HIV prevention strategy languishes.
    Science. 2018;359:1205.
    >> Share

    January 2018
  70. RAMSURAN V, Naranbhai V, Horowitz A, Qi Y, et al
    Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.
    Science. 2018;359:86-90.
    >> Share

    October 2017
  71. WENDER PA, Hardman CT, Ho S, Jeffreys MS, et al
    Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Science. 2017;358:218-223.
    >> Share

  72. COHEN MS, Corey L
    Broadly neutralizing antibodies to prevent HIV-1.
    Science. 2017;358:46-47.
    >> Share

    September 2017
  73. XU L, Pegu A, Rao E, Doria-Rose N, et al
    Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Science. 2017 Sep 20. pii: eaan8630. doi: 10.1126/science.aan8630.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016